Oli is a senior associate in our Cambridge office and is part of the Corporate Technology team.
Oli advises a range of companies in the tech and life sciences sectors on a variety of corporate matters, including venture capital investments, fundraisings, M&A and joint ventures.
|Since 2023||Senior Associate, Taylor Wessing|
|2021 - 2023||Associate, Taylor Wessing|
|2019 - 2020||Associate, Slaughter and May|
|2017 - 2019||Trainee solicitor, Slaughter and May|
|2019||Admitted as a solicitor in England & Wales|
|2016 - 2017||GDL & LPC, BPP Law School|
|2012 - 2015||BA Politics, University of Warwick|
Apollo Therapeutics closes $226.5 million series C financing
Nuclera raises additional capital for eProtein™ desktop bioprinter to close Series B funding at $58 million
Advising Placid0 on its acquisition by eyecare brand WALDO
Advising Nuclera on its Series B funding round